Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Total 13F shares
-
64,687,908
-
Share change
-
+5,802,955
-
Total reported value
-
$952,631,966
-
Put/Call ratio
-
81%
-
Price per share
-
$14.73
-
Number of holders
-
141
-
Value change
-
+$74,665,121
-
Number of buys
-
90
-
Number of sells
-
44
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q3 2020
As of 30 Sep 2020,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
141 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
64,687,908 shares.
The largest 10 holders included
HealthCor Management, L.P., NEA Management Company, LLC, FMR LLC, ORBIMED ADVISORS LLC, PICTET ASSET MANAGEMENT LTD, Avidity Partners Management LP, CITADEL ADVISORS LLC, GREAT POINT PARTNERS LLC, Point72 Asset Management, L.P., and Connor, Clark & Lunn Investment Management Ltd..
This page lists
144
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.